This opportunity funds facilities that produce and distribute reagents targeting brain cell types, including gene transfer, gene regulation, and genome engineering tools. The reagents support research in genetically tractable and less tractable systems such as primates and human tissue, facilitating translational neuroscience efforts. Facilities must serve a broad neuroscience community and produce reagents validated under related BRAIN Initiative projects.
Eligible applicants include a wide range of U.S.-based organizations such as nonprofits, institutions of higher education, tribal governments, for-profit organizations, state and local governments, and small businesses. Specific eligibility details are provided in the funding announcement.
